MOA of Teduglutide in sho bowel syndrome?
Correct Answer: GLP-2 inhibitor
Description: Ans. A. GLP-2 inhibitorGlucagon-like peptide-2 (GLP-2) - Impoant intestinotrophic growth factor & mediator of intestinal adaptation.FDA approved teduglutide (Gattex--NPS) to treat sho bowel syndrome in adult patients requiring additional nutrition from I.V. parenteral nutrition.Effectively improves fluid absorption.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now